🇺🇸 FDA
Pipeline program

610 100mg

SSGJ-610-BA-II-01

Phase 2 small_molecule active

Quick answer

610 100mg for Asthma is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Asthma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials